Skip to main content

Table 3 Adjusted difference in non-asthma drug costs per patient per year relative to control group

From: The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis

Base: No OCS exposure (Non-asthma control)   Adjusted cost differences Lower bound CI (95%) Upper bound CI (95%)
Low OCS exposure (Mild/Moderate asthma) Female £ 115a £ 82 £ 148
Male £ 106a £ 77 £ 135
Total £ 112a £ 80 £ 143
High OCS exposure (Severe asthma) Female £ 789a £ 652 £ 927
Male £ 744a £ 620 £ 868
Total £ 772a £ 641 £ 903
  1. Data are presented for males, females and with gender at the sample mean (total)
  2. aSignificant at α = 0.01